AIDS TREATMENT NEWS Issue #391, May 30, 2003
John S. James

A WALL STREET JOURNAL investigation showed great price variations in the marketing of some generic drugs in the U.S. For example, the so-called "average wholesale price" (AWP) for generic Prozac (fluoxetine), the most commonly prescribed generic in the U.S., was $2.66 a pill -- while in fact, pharmacies could actually buy the same pill for only 5 cents.

While most price differences are not this extreme, it has become standard practice for a handful of "pharmacy-benefit managers" to make big profits by exploiting secret price differences, which are usually not known even by large employers who are contracting for coverage of their employees. Although the article does not emphasize this point, the figures make it clear that the so-called "co-pay" (the $5, $10, $25, or other standard amount paid by the patient when picking up their medication) can actually be more than the full cost of the prescription -- suggesting that patients and their employers can unknowingly be paying for health insurance that actually charges more for certain medicines than if they had paid full price.

The article, "Hired to Cut Costs, Firms Find Profits in Generic Drugs," by Barbara Martinez, is on the front page of the March 31, 2003 WALL STREET JOURNAL.

Comment

At this time all antiretrovirals are patented in the U.S.; for them there are no generics, so the price issues are different. But HIV patients often need many prescriptions in addition to antiretrovirals.

A branch of treatment activism that develops expertise in the complex, irrational world of drug prices could educate the public about how to keep treatment available when it would otherwise be denied, in a country where drug prices are rising at a rate of about 15% per year. For example, it could help people in finding insurance, choosing among employer or other insurance plans, choosing among local, mail-order, and Internet pharmacies, knowing about discount-card programs, dealing with Medicaid and other public benefits, using patient-assistance programs, and knowing when it is better to fill a prescription out of pocket even if one has coverage. Such a movement could also advocate for needed changes in health plans, policies, and legislation.

Abusive drug pricing exists in part because when people need their medicine they may not have time and energy for price comparison. Today, when patients do have health care access decisions to make, they seldom have good advice available. That could change.

030530
ATN39109

Copyright © 2003 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .